scorecardresearch
Monday, July 21, 2025
TopicDr. Reddy

Topic: Dr. Reddy

Dr Reddy’s sees short-lived boom for Merck’s Covid pills in India

Even as oral Covid pills from Merck, Pfizer are being seen as game changers, generic drugmakers are getting a reality check that there may not be too much money on the table.

Dr Reddy’s inks licensing pact with Eli Lilly for Covid treatment drug Baricitinib

The agreement between the two firms comes days after Eli Lilly signed voluntary licensing agreements with Indian drug companies— Sun Pharma, Cipla and Lupin.

Dr. Reddy’s pushes for immediate right to sell suboxone copies

Indivior Plc’s Suboxone Film is the leading opioid addiction treatment in US.

On Camera

India’s TRP ecosystem needs a reset. Time to end BARC monopoly

A ratings monopoly in India has led to lack of technological variation, resulting in sluggish systems detached from market dynamics.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.